Could the mechanosensitive GPR133 receptor pathway be safely and effectively targeted in humans perhaps using a specific activator like AP503, to provide a superior, long-lasting therapeutic strategy for bone formation and osteoporosis reversal that avoids the severe side effects or lack of efficacy associated with current drugs?
Could the mechanosensitive GPR133 receptor pathway be safely and effectively targeted in humans perhaps using a specific activator like AP503, to provide a superior, long-lasting therapeutic strategy for bone formation and osteoporosis reversal that avoids the severe side effects or lack of efficacy associated with current drugs?
See also sciencealert.com repost:
https://news.ycombinator.com/item?id=46109446